GlaxoSmithKline Extends Collaboration With Aspen Pharmacare
December 01 2009 - 2:41AM
Dow Jones News
GlaxoSmithKline PLC (GSK.LN), the pharmaceutical and healthcare
company, said Tuesday it has completed the extension of its
strategic relationship with Aspen Pharmacare Holdings Ltd. and the
acquisition of a 19% shareholding in the South African based
pharmaceuticals company.
MAIN FACTS:
-On completion, Aspen issued 68.5 million ordinary shares to GSK
in consideration for the transfer of assets.
-Taken together with Aspen shares acquired by GSK between
signing and closing, this issue takes GSK's holding in Aspen to a
total of 81.7 million shares.
-By London Bureau, Dow Jones Newswires; Contact Ian Walker; +44 (0)20 7842 9296; ian.walker@dowjones.com